Prothena Corp. Plc Aktie News

DUBLIN, Ireland--(BUSINESS WIRE)---- $PRTA #prothena--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.

DUBLIN--(BUSINESS WIRE)---- $PRTA #amyloidosis--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today announced that it has named David Ford to a newly created position of Chief People Officer.

Prothena Corporation plc has an update coming on the phase 1 study using PRX012 for the treatment of patients with Alzheimer's Disease, expected in 2024. Company is already in the process of exploring the use of PRX012 for the treatment of patients with Alzheimer's Disease in the ongoing phase 3 ASCENT-2 study. The global market for Alzheimer's Disease is estimated to reach $15.5 billion by 2031.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena announced today the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate.

Prothena Corporation plc (PRTA) Q4 2023 Earnings Call Transcript

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today reported financial results for the fourth quarter and full year 2023.